Aquestive Therapeutics (AQST) Other Non Operating Income (2019 - 2023)
Aquestive Therapeutics (AQST) recorded quarterly Other Non Operating Income of -$1.0 million in Q4 2023, down 191.5% quarter-over-quarter from -$353000.0 in Q1 2023.
Aquestive Therapeutics (AQST) Other Non Operating Income (2019 - 2023) Analysis & Trends
Aquestive Therapeutics' Other Non Operating Income history runs 3 years deep, the most recent figure standing at -$1.0 million for Q4 2023.
- In Q4 2023, Other Non Operating Income changed N/A year-over-year to -$1.0 million; the TTM figure through Sep 2024 stood at -$1.0 million (down 191.5% YoY), while the FY2023 annual figure was -$1.4 million, changed N/A from the prior year.
- Other Non Operating Income was -$1.0 million for Q4 2023 at Aquestive Therapeutics, down from -$353000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $13.8 million in Q4 2021 to a low of -$4.9 million in Q3 2019.
- Historically, Other Non Operating Income has averaged $1.9 million across 3 years, with a median of -$691000.0 in 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Aquestive Therapeutics | 488.60 Mn | 377.87 Mn | 10.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -1.03 Mn |
| Mar 31, 2023 | -353,000.00 |
| Dec 31, 2021 | 13.82 Mn |
| Sep 30, 2019 | -4.90 Mn |